Reset
Showing 12 of 32 academic articles

FAM83A as a Potential Biological Marker Is Regulated by miR-206 to Promote Cervical Cancer Progression Through PI3K/AKT/mTOR Pathway

Li Rong, Haiyu Li, Zhaodong Li, Jing Ouyang et al. • Frontiers in Medicine (2020)

Background and Objective: Chemotherapy and radiotherapy are effective treatment options for cervical cancer (CC), but their efficacy is limited by short survival rate of about 5 years particularly for advance stage CC. Bioinformatics analys...

DOAJ Open Access (DOAJ) DOI: 10.3389/fmed.2020.608441

Barriers and facilitators of retention in care after cervical cancer screening: patients’ and healthcare providers’ perspectives

Judith Owokuhaisa, Eleanor Turyakira, Frank Ssedyabane, Deusdedit Tusubira et al. • BMC Women's Health (2024)

Abstract Background Cervical cancer continues to threaten women’s health, especially in low-resource settings. Regular follow-up after screening and treatment is an effective strategy for monitoring treatment outcomes. Consequently, underst...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12905-024-03343-1

Abnormal cervical cancer screening results among US Veteran and non-Veteran participants in the National Health Interview Survey (NHIS)

Elisheva R. Danan, Claire Than, Neetu Chawla, Katherine J. Hoggatt et al. • Preventive Medicine Reports (2023)

Female Veterans report cervical cancer risk factors at higher rates than non-Veterans. Using data from the National Health Interview Survey (NHIS), we tested whether Veterans with a recent cervical cancer screening test were more likely tha...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.pmedr.2023.102472

A missed opportunity: faith leaders and the HPV vaccination effort in Addis Ababa, Ethiopia

Wosene Berhanu, Simon Yigremachew, Claudia Hanson, Helena Avermark et al. • Global Health Action (2026)

Background Cervical cancer causes morbidity and mortality among women worldwide, particularly in low- and middle-income countries (LMICs). Human Papillomavirus (HPV) vaccine is crucial for cervical cancer prevention, yet the vaccination rat...

DOAJ Open Access (DOAJ) DOI: 10.1080/16549716.2026.2635822

Formative Research on HPV Vaccine Acceptance among Health Workers, Teachers, Parents, and Social Influencers in Uzbekistan

Sahil Khan Warsi, Siff Malue Nielsen, Barbara A. K. Franklin, Shukhrat Abdullaev et al. • Vaccines (2023)

Human papillomavirus (HPV) vaccines effectively prevent cervical cancer, most of which results from undetected long-term HPV infection. HPV vaccine introduction is particularly sensitive and complicated given widespread misinformation and v...

DOAJ Open Access (DOAJ) DOI: 10.3390/vaccines11040754

Trends in cervical cancer incidence and mortality in the United States, 1975–2018: a population-based study

Xianying Cheng, Ping Wang, Li Cheng, Feng Zhao et al. • Frontiers in Medicine (2025)

BackgroundCervical cancer incidence and mortality rates in the United States have substantially declined over recent decades, primarily driven by reductions in squamous cell carcinoma cases. However, the trend in recent years remains unclea...

DOAJ Open Access (DOAJ) DOI: 10.3389/fmed.2025.1579446

Application of Protein-Protein Interaction Network Analysis in Order to Identify Cervical Cancer miRNA and mRNA Biomarkers

Parinaz Tabrizi-Nezhadi, Habib MotieGhader, Masoud Maleki, Soner Sahin et al. • The Scientific World Journal (2023)

Cervical cancer (CC) is one of the world’s most common and severe cancers. This cancer includes two histological types: squamous cell carcinoma (SCC) and adenocarcinoma (ADC). The current study aims at identifying novel potential candidate ...

DOAJ Open Access (DOAJ) DOI: 10.1155/2023/6626279

Small cell neuroendocrine carcinoma of the cervix: From molecular basis to therapeutic advances

Angel Chao, Ren-Chin Wu, Chiao-Yun Lin, Ting-Chang Chang et al. • Biomedical Journal (2023)

Small cell neuroendocrine carcinoma of the cervix (SCNECC) is an uncommon but aggressive uterine malignancy, the cause of which is generally associated with human papillomavirus (HPV) infection. A lack of clinical trials and evidence-based ...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.bj.2023.100633